| Metric | შპს ბათუმის ენდოკრინოლოგიის ცენტრი | შპს ჰეალაინ ინტერნეიშნლ |
|---|---|---|
| Growth | ||
| Revenue | ₾2.2m₾1.9m | ₾3.7m₾3.6m |
| Revenue growth | 14.1% | 3.5% |
| Profitability | ||
| EBITDA | ₾160k₾267k | -₾63k-₾16k |
| EBITDA margin | 7.4%14.0% | -1.7%-0.5% |
| Net profit | ₾159k₾265k | -₾68k-₾44k |
| Net margin | 7.3%13.9% | -1.9%-1.2% |
| Balance sheet | ||
| Total assets | ₾2.1m₾2.2m | ₾621k₾665k |
| Total equity | ₾1.9m₾2.1m | ₾565k₾650k |
| ROE | 8.2%12.7% | -12.1%-6.8% |